Springer Nature AG & Co. KGaA/€SPG
1D1W1MYTD1Y5YMAX
Capital at risk
About Springer Nature AG & Co. KGaA
Springer Nature AG & Co. KGaA is a global academic publishing company specializing in research, health, and educational content. Formed in 2015 through the merger of Springer Science+Business Media and Holtzbrinck Publishing Group's Nature Publishing Group, Palgrave Macmillan, and Macmillan Education, the company publishes a wide array of scientific, technical, and medical journals under the Nature and Springer brands, as well as books and e-books across various disciplines. Headquartered in Berlin, Germany, with additional offices in London and New York City, Springer Nature operates in over 40 countries worldwide. The company has a significant presence in open access publishing, with 50% of its primary research articles published as open access in 2024, and continues to invest in technology and AI to enhance the publishing process. (,)
- Ticker
- €SPG
- Sector
- Communication
- Primary listing
- XETRA
- Employees
- 9,400
- Headquarters
- Berlin, Germany
- Website
- www.springernature.com
SPG Metrics
BasicAdvanced
€3.9B
12.08
€1.65
-
€0.83
4.17%
Price and volume
Market cap
€3.9B
52-week high
€24.05
52-week low
€14.72
Average daily volume
41K
Dividend rate
€0.83
Financial strength
Current ratio
0.921
Quick ratio
0.772
Long term debt to equity
0.707
Total debt to equity
0.718
Dividend payout ratio (TTM)
50.40%
Interest coverage (TTM)
4.32%
Profitability
EBITDA (TTM)
696.7
Gross margin (TTM)
86.86%
Net profit margin (TTM)
16.89%
Operating margin (TTM)
24.10%
Effective tax rate (TTM)
15.05%
Revenue per employee (TTM)
€210,000
Management effectiveness
Return on assets (TTM)
5.81%
Return on equity (TTM)
17.11%
Valuation
Price to earnings (TTM)
12.085
Price to revenue (TTM)
2.024
Price to book
1.97
Price to tangible book (TTM)
-1.96
Price to free cash flow (TTM)
8.921
Free cash flow yield (TTM)
11.21%
Free cash flow per share (TTM)
2.231
Dividend yield (TTM)
4.17%
Forward dividend yield
4.17%
Growth
Revenue change (TTM)
3.40%
Earnings per share change (TTM)
103.50%
Bulls say / Bears say
Underlying revenue in H1 2026 increased 6.2% to €939.8 million, driven by Research segment strength across the full open access, Nature and Springer journals portfolios. (Springer Nature IR)
Adjusted operating profit in H1 2026 rose 7.7% underlying to €246.2 million, reflecting improved product mix and operating leverage. (Springer Nature IR)
Springer Nature signed 19 new transformative agreements in H1 2026, bringing the total to 101 agreements covering over 4 400 institutions and accelerating high-margin open access growth. (Springer Nature IR)
Springer Nature divested its consumer media businesses (Scientific American and Spektrum der Wissenschaft) in H1 2026, reducing diversification and increasing reliance on academic publishing revenues. (Reuters)
Springer Nature CFO Alexandra Dambeck will leave by end-2026, creating potential leadership and execution risk during a critical phase of strategic initiatives. (Reuters)
Currency headwinds remain a risk after a weak dollar in 2025 dampened reported revenue growth by 3.2 ppts and margins by 0.5 ppts, with ongoing FX volatility potentially impacting future reported results. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 2 Sept 2026.
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.